Results 191 to 200 of about 1,582,405 (310)

Global Overview, Emerging Patterns, and Networking of West Nile Virus Research: A Scientometric Analysis. [PDF]

J Glob Infect Dis
Espinoza-Carhuancho F, Cabanillas-Lazo M, Alvitez-Temoche D, Mayta-Tovalino F.   +3 more
europepmc   +1 more source

El Sur Global bajo análisis forense

Este artículo se pregunta si es pertinente el uso de la expresión «Sur global» desde un punto de vista analítico y explicativo, pese a ser un concepto esencialmente contestado, que combina uso performativo y analítico y hace referencia a una realidad en construcción. Ello se hace desde un análisis forense, centrado en hechos y evidencias.
openaire   +1 more source

L’Allemagne sur la voie de l’économie globale [PDF]

Regards sur l’économie allemande, 2007
openaire   +2 more sources

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Prevalence and Severity of Oral Conditions in Elite Athletes: A Systematic Review and Meta-Analysis. [PDF]

Dent J (Basel)
Campana Zamudio F, Aleman Soto VS, Azañedo D, Hernández-Vásquez A.   +3 more
europepmc   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Ecological Drivers of Plasmid-Mediated Antimicrobial Resistance in Aquaculture. [PDF]

Microb Ecol
Cota Ortega LE, Quiroz-Guzmán E, Balcázar JL.   +2 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Projet de loi 2 du Québec : un coup de massue pour le système de santé. [PDF]

CMAJ
Charlebois S, Flegel K, Stanbrook MB.
europepmc   +1 more source